Home » Stocks » NOVN

Novan, Inc. (NOVN)

Stock Price: $1.10 USD -0.09 (-7.56%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Pre-market: $1.15 +0.05 (4.55%) Apr 19, 4:31 AM
Market Cap 166.82M
Revenue (ttm) 4.92M
Net Income (ttm) -29.29M
Shares Out 98.81M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $1.10
Previous Close $1.19
Change ($) -0.09
Change (%) -7.56%
Day's Open 1.10
Day's Range 1.07 - 1.14
Day's Volume 4,496,477
52-Week Range 0.30 - 2.59

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

MORRISVILLE, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, wi...

1 month ago - GlobeNewsWire

– B-SIMPLE4 pivotal Phase 3 trial evaluating SB206 as a treatment for molluscum contagiosum progressing with top-line efficacy results targeted before the end of Q2 2021 –

1 month ago - GlobeNewsWire

– Topline data on track for targeted readout before the end of Q2 2021 –

2 months ago - GlobeNewsWire

MORRISVILLE, N.C., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it has received written notice from The Nasdaq Stock Market LLC (“Nasdaq”...

2 months ago - GlobeNewsWire

– B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum reaches 90% enrollment with topline data targeted for Q2 2021 –

2 months ago - GlobeNewsWire

NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cl...

3 months ago - PRNewsWire

MORRISVILLE, N.C., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, wil...

3 months ago - GlobeNewsWire

– Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing –

3 months ago - GlobeNewsWire

– Completion of patient enrollment targeted for Q1 2021 with readout of topline results targeted for Q2 2021 –

4 months ago - GlobeNewsWire

NEW YORK, Dec. 14, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cl...

4 months ago - PRNewsWire

– T rading on Nasdaq Capital Market is expected to begin on November 5, 2020 –

5 months ago - GlobeNewsWire

– Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 –

5 months ago - GlobeNewsWire

- Live moderated video webcast discussion between members of management and Key Opinion Leader, John Browning, MD, FAAD, FAAP, MBA on Tuesday October 27th at 12:00 PM ET - Live moderated video webcast d...

5 months ago - GlobeNewsWire

- F irst demonstration of antiviral effect of nitric oxide -based medicine against SARS-CoV-2 in an in vitro model that mimics the human airway epithelium

6 months ago - GlobeNewsWire

- John M. Gay , V ice P resident , Finance and Corporate Controller with over 20 years of financial and accounting experience appointed as Chief Financial Officer

6 months ago - GlobeNewsWire

- Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 -

7 months ago - GlobeNewsWire

- Live video webcast with President and CEO, Paula Brown Stafford, on Monday, September 14th at 4:00 PM EDT -

7 months ago - GlobeNewsWire

- Topline results targeted for Q2 2021, less than a year away -

7 months ago - GlobeNewsWire

- Clinical sites actively enrolling patients -

7 months ago - GlobeNewsWire

MORRISVILLE, N.C., July 28, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced an expanded role of Paula Brown Stafford, President and Chief Executive O...

8 months ago - GlobeNewsWire

MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2020 Annual Meeting ...

8 months ago - GlobeNewsWire

MORRISVILLE, N.C., June 25, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company anticipates that its current cash position will be sufficient...

9 months ago - GlobeNewsWire

MORRISVILLE, N.C., June 24, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that Paula Brown Stafford, the Company’s President and Chief Executive Officer...

9 months ago - GlobeNewsWire

MORRISVILLE, N.C., April 30, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that the Company has received meeting minutes from the April 1, 2020 Type C m...

11 months ago - GlobeNewsWire

MORRISVILLE, N.C., April 20, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that it has engaged H.C. Wainwright & Co., LLC (“H.C. Wainwright & Co.”) to a...

11 months ago - GlobeNewsWire

Top Ranked Momentum Stocks to Buy for April 6th

Other stocks mentioned: CHWY, FRO, TNK
1 year ago - Zacks Investment Research

MORRISVILLE, N.C., April 03, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that the Company has conducted its Type C meeting with the U.S. Food and Drug...

1 year ago - GlobeNewsWire

Top Ranked Momentum Stocks to Buy for April 2nd

Other stocks mentioned: AYTU, DHT, EURN
1 year ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for March 30th

Other stocks mentioned: FTSV, MRNA, VIRT
1 year ago - Zacks Investment Research

MORRISVILLE, N.C., March 26, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company’s previously announced registered direct offering ...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., March 24, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it has entered into definitive agreements with several institutional and...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., March 23, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced data from the prospectively planned safety evaluation through Week 24 as part...

1 year ago - GlobeNewsWire

Inside the top-ranked stocks that have been exhibiting rising P/E ratios.

Other stocks mentioned: CFMS, KL, LONE, UEC
1 year ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for March 11th

Other stocks mentioned: STMP, VNET, ZM
1 year ago - Zacks Investment Research

MORRISVILLE, N.C., March 03, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company’s previously announced underwritten public offerin...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced the pricing of the Company's previously announced underwritten public offering...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN) today announced that it intends to offer and sell a combination of shares of its common stock...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has received approximately $1.0 million funding from the Nati...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today provided an update on several aspects of its Phase 3 B-SIMPLE program (B-SIMPLE1 and B-S...

1 year ago - GlobeNewsWire

Shares of Novan Inc. novn fell 72% in premarket trading on Friday after the biotechnology company said Thursday that its experimental treatment for molluscum contagiosum, a type of skin infection, had f...

1 year ago - Market Watch

MORRISVILLE, N.C., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that Paula Brown Stafford, currently President and Chief Operating Officer (“C...

1 year ago - GlobeNewsWire

Novan (NOVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

MORRISVILLE, N.C., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has submitted a request for a pre-IND meeting with the U.S. F...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company’s Phase 2 molluscum study, designed to evaluate topical nitri...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has received a grant from the U.S. Department of Defense’s (...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Compensation Committee of Novan’s Board of Directors granted stock o...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has entered into a Common Stock Purchase Agreement (the “Agr...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced the appointment of Michelle Patterson as Vice President of Project Management.

1 year ago - GlobeNewsWire

About NOVN

Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-base... [Read more...]

Industry
Biotechnology
IPO Date
Sep 21, 2016
CEO
G. Kelly Martin
Employees
23
Stock Exchange
NASDAQ
Ticker Symbol
NOVN
Full Company Profile

Financial Performance

In 2020, Novan's revenue was $4.92 million, an increase of 0.49% compared to the previous year's $4.90 million. Losses were -$29.29 million, -3.57% less than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for Novan stock is "Buy" and the 12-month stock price forecast is 2.75.

Price Target
$2.75
Analyst Consensus: Buy